These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 5768430)

  • 21. Further studies on the effect of a transplanted methylcholanthrene-induced fibrosarcoma on humoral immunity in CBA mice.
    James K; Milne I; Warr G
    Clin Exp Immunol; 1974 Oct; 18(2):243-50. PubMed ID: 4468197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of artificial metastases of methylcholanthrene-induced rat sarcomas by autoimmunization of the autochthonous hosts.
    Takeda K; Kikuchi Y; Yamawaki S; Ueda T; Yoshiki T
    Cancer Res; 1968 Oct; 28(10):2149-54. PubMed ID: 5696943
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of neuraminidase treatment to influence tumorigenicity or immunogenicity of syngeneically transplanted rat tumour cells.
    Pimm MV; Cook AJ; Baldwin RW
    Eur J Cancer (1965); 1978 Aug; 14(8):869-78. PubMed ID: 689056
    [No Abstract]   [Full Text] [Related]  

  • 24. The transfer of tumor immunity with syngeneic RNA.
    Deckers PJ; Ramming KP; Pilch YH
    Ann N Y Acad Sci; 1973 May; 207():442-53. PubMed ID: 4517720
    [No Abstract]   [Full Text] [Related]  

  • 25. BCG immunotherapy of rat tumors of defined immunogenicity.
    Baldwin RW; Pimm MV
    Natl Cancer Inst Monogr; 1973 Dec; 39():11-9. PubMed ID: 4595312
    [No Abstract]   [Full Text] [Related]  

  • 26. Measurement of H-2 antigen and immunogenicity of methylcholanthrene-induced murine sarcomas.
    Pearson T; Sikora K; Lennox E
    Br J Cancer; 1978 Apr; 37(4):530-5. PubMed ID: 77161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
    Simmons RL; Rios A; Ray PK
    J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
    [No Abstract]   [Full Text] [Related]  

  • 28. Host and tumor modifications associated with serial heterotransplantation of tumors through immunologically tolerant animals.
    Suciu-Foca N; Dumitrescu V; Lazar C; Nachtigal M
    Cancer Res; 1970 Jun; 30(6):1681-91. PubMed ID: 4394119
    [No Abstract]   [Full Text] [Related]  

  • 29. Fetal antigens shared as transplantation rejection antigens on chemically induced mouse and hamster sarcomas.
    Coggin JH; Adkinson L; Anderson NG
    Cancer Res; 1980 May; 40(5):1568-73. PubMed ID: 6768448
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 31. ISOANTIGENIC PROPERTIES OF TUMORS TRANSGRESSING HISTOCOMPATIBILITY BARRIERS OF THE H-2 SYSTEM.
    MOELLER E
    J Natl Cancer Inst; 1964 Dec; 33():979-89. PubMed ID: 14241790
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of immune lymphocytes with the mixtures of target cells possessing selected specificities of the H-2 immunizing allele.
    Brondz BD; Snegiröva AE
    Immunology; 1971 Apr; 20(4):457-68. PubMed ID: 5553067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen-reactive cells in the spleen of mice with methylcholanthrene-induced sarcoma.
    Yakimenko LV; Umanskii YA
    Bull Exp Biol Med; 1974 Nov; 77(5):551-3. PubMed ID: 4474897
    [No Abstract]   [Full Text] [Related]  

  • 34. Antitumour immunity--1. Differential response of neuraminidase-treated and x-irradiated tumour vaccine.
    Ray PK; Thakur VS; Sundaram K
    Eur J Cancer (1965); 1975 Jan; 11(1):1-8. PubMed ID: 1132396
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of active immune state by multinucleate tumour cells in mice.
    Liao SK; Carr DH
    Experientia; 1973 May; 29(5):597-9. PubMed ID: 4354198
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of anesthesia and amputation on tumor and general immunity of the mouse.
    Humphrey LJ; Frederickson EL; Amerson JR
    J Surg Res; 1970 Jun; 10(6):265-70. PubMed ID: 5462596
    [No Abstract]   [Full Text] [Related]  

  • 37. Concomitant immunity and specific desensitization in murine tumor hosts.
    Vaage J
    Isr J Med Sci; 1973 Mar; 9(3):332-43. PubMed ID: 4710041
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
    Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
    Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
    [No Abstract]   [Full Text] [Related]  

  • 39. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.
    Kearney R; Nelson DS
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.